The peptide industry has witnessed a significant increase, with imports from China reaching $328 million in just nine months. Surprisingly, the fastest-growing consumers engaging with these products are not bodybuilders but women in their 30s, 40s, and 50s who are often dismissed by healthcare providers despite experiencing troubling symptoms such as brain fog and joint pain.
In this discussion, I delve into the use of peptides like BPC-157 and TB-500, emphasizing the alarming fact that there are no randomized controlled trials confirming their efficacy or safety in humans. Women’s health is frequently compromised by the dismissal that their lab results are ‘fine’ while they suffer from debilitating symptoms.
There are better-supported alternatives! Hormone replacement therapy (HRT) can protect the brain when applied correctly, and crucial lifestyle factors such as resistance training, adequate protein intake, and proper sleep are indispensable for optimal brain health. These methods are backed by substantial scientific evidence, unlike many of the trending peptide products marketed online.
It’s critical to understand the risks associated with unregulated products, as 40% of peptide imports have been found to contain incorrect dosages or undeclared ingredients, with potential side effects including nausea and kidney failure.
For women aged 30 and above, mitigating the risk of Alzheimer’s is achievable through a comprehensive, science-backed protocol, which can be explored further here:
https://go.neuroathletics.com.au/youtube-sales-page
Explore more through the Neuro Experience, which promotes conversations around brain science and health.
If you’re interested in lifestyle interventions, I emphasize the importance of seeking verified medical advice rather than experimenting with untested substances from dubious sources. This can drastically transform brain health and overall wellbeing.
For more insights, subscribe to the Neuro Athletics Newsletter:
https://bit.ly/3ewI5P0
Additional resources and research studies discussed include:
– Emerging Use of BPC-157 in Orthopaedic Sports Medicine: https://pubmed.ncbi.nlm.nih.gov/40756949/
– FDA Bulk Drug Substances — BPC-157 Category 2 Classification: https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-nominated-use-compounding
I’m Louisa Nicola, a clinical neurophysiologist focused on Alzheimer’s prevention and actionable strategies for peak brain performance.
Stay informed, prioritize your brain health, and let’s combat Alzheimer’s together!
By Louisa Nicola